RESMED INC
For the period ended Mar 31, 2024. Filed Apr 26, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed Apr 26, 2024
RMD$235.74+0.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Financial Information Financial Statements Condensed Consolidated Balance Sheets (Unaudited)
| PART I – FINANCIAL INFORMATION | Item 1 |
|---|
Item 1. Financial Statements
Condensed Consolidated Balance Sheets (Unaudited)
(In US$ and in thousands, except share and per share data)
| March 31,2024 | June 30,2023 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $237,910 | $227,891 |
| Accounts receivable, net of allowances of $19,810 and $23,603 at March 31, 2024 and June 30, 2023, respectively | 779,265 | 704,909 |
| Inventories (note 3) | 829,458 | 998,012 |
| Prepaid expenses and other current assets (note 3) | 504,663 | 437,018 |
| Total current assets | 2,351,296 | 2,367,830 |
| Non-current assets: | ||
| Property, plant and equipment, net (note 3) | 539,743 | 537,856 |
| Operating lease right-of-use assets | 147,075 | 127,955 |
| Goodwill (note 4) | 2,835,993 | 2,770,299 |
| Other intangible assets, net (note 3) | 501,024 | 552,341 |
| Deferred income taxes | 162,106 | 132,974 |
| Prepaid taxes and other non-current assets | 277,325 | 262,453 |
| Total non-current assets | 4,463,266 | 4,383,878 |
| Total assets | $6,814,562 | $6,751,708 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $177,445 | $150,756 |
| Accrued expenses | 356,076 | 365,660 |
| Operating lease liabilities, current | 24,182 | 21,919 |
| Deferred revenue | 150,753 | 138,072 |
| Income taxes payable | 54,671 | 72,224 |
| Short-term debt, net (note 7) | 9,903 | 9,902 |
| Total current liabilities | 773,030 | 758,533 |
| Non-current liabilities: | ||
| Deferred revenue | 131,981 | 119,186 |
| Deferred income taxes | 86,564 | 90,650 |
| Operating lease liabilities, non-current | 136,313 | 116,853 |
| Other long-term liabilities | 47,550 | 68,166 |
| Long-term debt, net (note 7) | 997,047 | 1,431,234 |
| Long-term income taxes payable | 12,157 | 37,183 |
| Total non-current liabilities | 1,411,612 | 1,863,272 |
| Total liabilities | 2,184,642 | 2,621,805 |
| Commitments and contingencies (note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.01 par value, 2,000,000 shares authorized; none issued | — | — |
| Common stock, $0.004 par value, 350,000,000 shares authorized; 189,319,079 issued and 146,886,657 outstanding at March 31, 2024 and 188,900,583 issued and 147,064,349 outstanding at June 30, 2023 | 588 | 588 |
| Additional paid-in capital | 1,847,938 | 1,772,083 |
| Retained earnings | 4,769,963 | 4,253,016 |
| Treasury stock, at cost, 42,432,422 shares at March 31, 2024 and 41,836,234 shares at June 30, 2023 | (1,723,263) | (1,623,256) |
| Accumulated other comprehensive loss | (265,306) | (272,528) |
| Total stockholders’ equity | 4,629,920 | 4,129,903 |
| Total liabilities and stockholders’ equity | $6,814,562 | $6,751,708 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.